M.D. Sass LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.8M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$28.6M |
| 3 |
Avantor
AVTR
|
+$28.4M |
| 4 |
Cencora
COR
|
+$19.9M |
| 5 |
Copart
CPRT
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$31.2M |
| 2 |
East-West Bancorp
EWBC
|
+$19.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$15.4M |
| 4 |
Match Group
MTCH
|
+$14.5M |
| 5 |
MasTec
MTZ
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.27% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 12.07% |
| 4 | Technology | 7.62% |
| 5 | Communication Services | 7.15% |
Similar funds
M.D. Sass LLC's Q1 2023 Portfolio in Review
As of Q1 2023, M.D. Sass LLC held 39 positions worth $802M, up 18% from $681M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
M.D. Sass LLC deployed $89.6M of net new capital in Q1 2023, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 266,011 shares worth $29.2M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $15.4M trimmed.
- M.D. Sass LLC's largest Q1 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 266,011 shares worth $29.2M.
- M.D. Sass LLC added most to Cencora in Q1 2023, an estimated $19.9M increase.
- M.D. Sass LLC's biggest Q1 2023 reduction was Alphabet (Google) Class A, cutting an estimated $15.4M.
- M.D. Sass LLC fully exited First Republic Bank in Q1 2023, selling an estimated $31.2M.
- M.D. Sass LLC's ten largest holdings make up 58% of its $802M portfolio in Q1 2023.
- M.D. Sass LLC opened 11 new positions and closed 6 in Q1 2023.
- M.D. Sass LLC's portfolio value rose 18% quarter-over-quarter to $802M.
Based on M.D. Sass LLC's 13F filing for Q1 2023, filed 15 May 2023.